Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Institute for Medical Science of Aging, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan.
J Neurol. 2017 Nov;264(11):2249-2257. doi: 10.1007/s00415-017-8604-y. Epub 2017 Sep 22.
Multiple system atrophy (MSA) manifests as a combination of dysautonomia and motor symptoms/signs. However, rare cases presenting with autonomic failures in absence of motor symptoms/signs until their deaths have been reported and are referred to as non-motor MSA. To clarify pathological findings underlying non-motor MSA patients, we analyzed consecutively autopsied 161 patients with MSA. In results, four patients were identified as having non-motor MSA, who showed isolated autonomic disorders throughout their lives and had minimal pathological changes in the motor systems. We also identified two patients with pathologically minimal MSA, who had minimal pathological involvement in the motor systems and presented with definite parkinsonism and dysautonomia. Survival durations of the non-motor MSA patients were much shorter (1.3-2.0 years) than those of the classical MSA patients (3.0-7.0 years), and the causes of death were all sudden death. The medullary serotonergic neurons were severely involved in the non-motor MSA patients in comparison with the classical MSA patients. Also, one of the pathologically minimal MSA patients had died suddenly and exhibited marked involvement of the medullary serotonergic neurons. The involvement of the medullary catecholaminergic or cholinergic neurons did not differ in severities among the groups. We conclude that non-motor MSA may be a pathological variant of MSA that preferentially involves the medullary serotonergic neurons and autonomic systems in association with poor prognosis.
多系统萎缩(MSA)表现为自主神经功能障碍和运动症状/体征的组合。然而,已经报道了罕见的病例,这些病例在没有运动症状/体征的情况下出现自主神经衰竭,直到死亡,被称为非运动性 MSA。为了阐明非运动性 MSA 患者的病理发现,我们分析了连续尸检的 161 例 MSA 患者。结果,发现 4 例患者为非运动性 MSA,他们一生都表现出孤立的自主神经障碍,运动系统的病理变化极小。我们还发现了 2 例病理上最小的 MSA 患者,他们的运动系统病理受累最小,表现出明确的帕金森病和自主神经功能障碍。非运动性 MSA 患者的生存时间明显缩短(1.3-2.0 年),明显短于经典 MSA 患者(3.0-7.0 年),且死亡原因均为猝死。与经典 MSA 患者相比,非运动性 MSA 患者的延髓 5-羟色胺能神经元严重受累。此外,一名病理上最小的 MSA 患者突然死亡,延髓 5-羟色胺能神经元明显受累。各组间延髓儿茶酚胺能或胆碱能神经元的受累严重程度无差异。我们得出结论,非运动性 MSA 可能是 MSA 的一种病理变异,优先累及延髓 5-羟色胺能神经元和自主神经系统,预后不良。